Glutamate Receptor Ionotropic, [NMDA] subunit zeta-1 is a protein that in humans is encoded by the GRIN1gene.
Gene
The gene consists of 21 exons and undergoes alternative splicing, producing transcript variants that encode different GluN1 isoforms. Alternative splicing affects both the N-terminal region, through inclusion or exclusion of exon 5, and the C-terminal region. The sequence of exon 5 is identical in vertebrates, and its alternative splicing has been demonstrated in humans, mice and rats.
GluN1-1a, GluN1-1b, GluN1-2a and GluN1-2b contain the C2 cassette, whereas GluN1-3a, GluN1-3b, GluN1-4a and GluN1-4b contain the alternative C2' cassette.
Function
GluN1 is obligatory for NMDA receptor function and contains the binding site for the co-agonist glycine. NMDA receptors play a key role in synaptic plasticity, which is believed to underlie learning and memory.
Cell-specific factors are thought to regulate the expression of GluN1 isoforms, potentially contributing to the functional diversity of NMDA receptors. GluN1-1a is the most abundantly expressed isoform across the central nervous system (CNS). Activity-dependent alternative splicing of the C-terminal region regulates GluN1 export from the endoplasmic reticulum and delivery of NMDA receptors to synapses. The functional significance of C-terminal splice variants varies across the CNS.
Schröder HC, Perovic S, Kavsan V, Ushijima H, Müller WE (1998). "Mechanisms of prionSc- and HIV-1 gp120 induced neuronal cell death". Neurotoxicology. 19 (4–5): 683–688. PMID9745929.
Adriani W, Felici A, Sargolini F, Roullet P, Usiello A, Oliverio A, etal. (November 1998). "N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes". Experimental Brain Research. 123 (1–2): 52–59. doi:10.1007/s002210050544. PMID9835392. S2CID8388670.
Dingledine R, Borges K, Bowie D, Traynelis SF (March 1999). "The glutamate receptor ion channels". Pharmacological Reviews. 51 (1): 7–61. doi:10.1016/S0031-6997(24)01394-2. PMID10049997.
Zimmer M, Fink TM, Franke Y, Lichter P, Spiess J (July 1995). "Cloning and structure of the gene encoding the human N-methyl-D-aspartate receptor (NMDAR1)". Gene. 159 (2): 219–223. doi:10.1016/0378-1119(95)00044-7. PMID7622053.
Foldes RL, Rampersad V, Kamboj RK (September 1993). "Cloning and sequence analysis of cDNAs encoding human hippocampus N-methyl-D-aspartate receptor subunits: evidence for alternative RNA splicing". Gene. 131 (2): 293–298. doi:10.1016/0378-1119(93)90309-Q. PMID8406025.
Collins C, Duff C, Duncan AM, Planells-Cases R, Sun W, Norremolle A, etal. (July 1993). "Mapping of the human NMDA receptor subunit (NMDAR1) and the proposed NMDA receptor glutamate-binding subunit (NMDARA1) to chromosomes 9q34.3 and chromosome 8, respectively". Genomics. 17 (1): 237–239. doi:10.1006/geno.1993.1311. PMID8406459.
Lannuzel A, Lledo PM, Lamghitnia HO, Vincent JD, Tardieu M (November 1995). "HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons". The European Journal of Neuroscience. 7 (11): 2285–2293. doi:10.1111/j.1460-9568.1995.tb00649.x. PMID8563977. S2CID27201873.
Corasaniti MT, Melino G, Navarra M, Garaci E, Finazzi-Agrò A, Nisticò G (September 1995). "Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase". Neurodegeneration. 4 (3): 315–321. doi:10.1016/1055-8330(95)90021-7. PMID8581564.